PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,344,600 | -17.1% | 60,000 | +41.2% | 0.01% | -70.6% |
| Q4 2022 | $1,622,225 | -46.1% | 42,500 | -29.2% | 0.02% | -37.0% |
| Q3 2022 | $3,012,000 | +0.2% | 60,000 | -20.0% | 0.03% | +17.4% |
| Q2 2022 | $3,005,000 | +7.4% | 75,000 | 0.0% | 0.02% | -39.5% |
| Q1 2022 | $2,798,000 | -6.3% | 75,000 | 0.0% | 0.04% | +26.7% |
| Q4 2021 | $2,987,000 | -10.8% | 75,000 | -16.7% | 0.03% | -33.3% |
| Q3 2021 | $3,349,000 | +32.1% | 90,000 | +50.0% | 0.04% | +45.2% |
| Q2 2021 | $2,536,000 | +149.9% | 60,000 | +100.0% | 0.03% | +10.7% |
| Q3 2019 | $1,015,000 | +351.1% | 30,000 | +500.0% | 0.03% | +460.0% |
| Q2 2019 | $225,000 | -76.1% | 5,000 | -80.0% | 0.01% | -58.3% |
| Q1 2019 | $941,000 | -30.5% | 25,000 | -50.0% | 0.01% | -57.1% |
| Q1 2018 | $1,353,000 | +35.2% | 50,000 | -16.7% | 0.03% | +27.3% |
| Q4 2017 | $1,001,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |